Literature DB >> 5554938

Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism.

H K Brodie, D L Murphy, F K Goodwin, W E Bunney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5554938     DOI： 10.1002/cpt1971122part1218

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  10 in total

1.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

Authors:  A Abi-Dargham; J Rodenhiser; D Printz; Y Zea-Ponce; R Gil; L S Kegeles; R Weiss; T B Cooper; J J Mann; R L Van Heertum; J M Gorman; M Laruelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Neurochemical and psychoanalytical approaches to mania.

Authors:  J C Cookson; T Silverstone
Journal:  Proc R Soc Med       Date:  1977

Review 3.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

Review 4.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

Review 5.  Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

6.  Malignant pheochromocytoma. Effect of oral alpha-methyl-p-tyrosine upon catecholamine metabolism.

Authors:  J H Hengstmann; R Gugler; H J Dengler
Journal:  Klin Wochenschr       Date:  1979-04-01

Review 7.  alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

8.  Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression.

Authors:  J Douglas Bremner; Meena Vythilingam; Chin K Ng; Eric Vermetten; Ahsan Nazeer; Dan A Oren; Robert M Berman; Dennis S Charney
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships.

Authors:  E Widerlöv; T Lewander
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-09       Impact factor: 3.000

10.  Molecular docking study of catecholamines and [4-(propan-2-yl) phenyl]carbamic acid with tyrosine hydroxylase.

Authors:  Zahida Parveen; Muhammad Sulaman Nawaz; Shazi Shakil; Nigel H Greig; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.